TuHURA Biosciences, Inc.
HURA· Nasdaq
HURATuHURA Biosciences, Inc.
Filed Mar 31, 2025 · 10-K · 90 days after period end · 0000950170-25-047921
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$6.00M | -$6.73M | -$3.82M | -$2.58M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 31, 2025 · 90 d after period end
